Pages that link to "Q37511580"

The following pages link to Characterization of genetic variation and 3'-azido-3'-deoxythymidine- resistance mutations of human immunodeficiency virus by the RNase A mismatch cleavage method (Q37511580):

Displaying 22 items.

• Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine (Q28343184) (← links)
• Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents (Q28378547) (← links)
• A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors (Q32157822) (← links)
• Initial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence (Q33570433) (← links)
• Managing resistance to anti-HIV drugs: an important consideration for effective disease management. (Q33588535) (← links)
• Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis (Q33675233) (← links)
• Assessing dissimilarity of genes by comparing their RNAse A mismatch cleavage patterns (Q33969213) (← links)
• Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology. (Q34174981) (← links)
• RNase cleavage-based methods for mutation/SNP detection, past and present (Q34347939) (← links)
• Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene (Q35132164) (← links)
• Emergence of Mutant HIV Reverse Transcriptase Conferring Resistance to AZT (Q35174378) (← links)
• Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine. (Q36518384) (← links)
• Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. (Q36636446) (← links)
• Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture. (Q36646318) (← links)
• Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs. (Q38354757) (← links)
• Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. (Q40284727) (← links)
• HIV-1 Drug Resistance: Molecular Pathogenesis and Laboratory Monitoring (Q40393212) (← links)
• Diagnosis of HIV‐1 infection by detection of antibody IgG to HIV‐1 in urine with ultrasensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using recombinant proteins as antigens (Q40393444) (← links)
• Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice (Q40884087) (← links)
• Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences (Q40931968) (← links)
• Xenotropic murine leukemia virus-related virus is susceptible to AZT. (Q41879645) (← links)
• Selection response in finite populations (Q42967304) (← links)